metformin vs glp 1 for pcos GLP-1s Lead to Greater Weight Loss and A1C Improvement Than in Patients with Therapeutic Potential of Glucagon-like Peptide-1

Once on the market, Adlyxin (lixisenatide) had a relatively small footprint, partly because by 2016 many clinicians leaned toward the more potent GLP-1 RAs

Expansion of Indications for Existing Drugs: Existing GLP-1 receptor agonists are receiving regulatory approvals for expanded uses, including the treatment of obesity and cardiovascular diseases

i NKT cells can produce various cytokines, both pro-inflammatory and anti-inflammatory, meaning their involvement in immune responses can be either protective or harmful depending on the environment [160]

GLP-1 receptor agonists and kidney protection

In 2024, the global pharmaceutical market witnessed unprecedented growth, with the top-selling drugs collectively generating over $116 billion in revenue

A plant-forward look at the drugs and the food-first levers